Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 2 November 2026.

Announcements

1,179

Total raised

£24.7B

disclosed amounts

This month

£9.0M

raised so far

Series A
£13.9M

The financing round was backed by BGF, Parkwalk, and Meltwind to drive therapeutics discovery in autoimmune and other common diseases.

"Our founders have led the field by developing technology to map 3D interactions on a whole-genome scale, and integrating these data with comprehensive multi-omics datasets. We now have the technological capabilities to decipher the causal biology that drives complex and common genetic diseases, with the potential to develop truly effective new blockbuster therapies."
— Dietrich Stephan, Chair
Series A
$100M

The financing was co-led by New Enterprise Associates and Temasek with participation from a broad group of strategic investors.

"Next-generation AI compute, clean air and water and sustainable energy – these multi-billion-dollar global challenges share a common barrier: materials. CuspAI’s mission is to change that. In just a year, we’ve gone from concept to partnerships with world leaders in automotive, semiconductors, energy, and climate."
— Chad Edwards, Co-founder
Series A
£17.7M

The Series A round was led by Notion Capital with participation from multiple venture firms and angel investors.

"Every Trust we meet tells us the same story: they need qualified staff now, but they cannot risk patient safety or compliance. Our platform gives them speed without compromise, predictability without cost inflation, and sustainability where locum dependency has become unsustainable. TERN Group’s mission is for every placement to set off a chain reaction: anurse arriving on time means a ward runs smoothly, which means patients get treated faster. This raise enables us to make those chain reactions happen at scale, across the UK and beyond."
— Avinav Nigam
Series A
$19.0M

The London healthtech startup secured backing from Balderton and Pentland to scale manufacturing and regulatory pathways for its continuous glucose monitor.

"During their time at Imperial, they worked in one of the pioneering research groups that invented modern glucose strip technology. Their combined expertise in electrochemistry, biosensing, and medical device engineering laid the foundation for Sava’s next-generation biosensor platform."
— Renato Circi